Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. (ETON) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 65 transactions totaling $26.1M, demonstrating a bearish sentiment with -$18.5M in net insider flow. The most recent transaction on Dec 12, 2025 involved a transaction of 6,732 shares valued at $113.3K.
ETON Insider Activity Summary
Who Is Buying ETON Stock?
No significant insider buying has been recorded for ETON in the recent period.
Who Is Selling ETON Stock?
No significant insider selling has been recorded for ETON in the recent period.
Is Eton Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ETON is bearish with an Insider Alignment Score of 15/100 and a net flow of -$18.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ETON Frequently Asked Questions
Understanding ETON Insider Activity
Insider trading at Eton Pharmaceuticals, Inc. (ETON) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading ETON stock, having executed 65 transactions in the past 90 days. The most active insider is Management Inc. Opaleye (Executive), who has made 41 transactions totaling $14.3M.
Related Tools
Track Eton Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at ETON file new Form 4 transactions